Literature DB >> 4044033

Adenylate cyclase activity of a 68,000-molecular-weight protein isolated from the outer membrane of Bordetella bronchiseptica.

P Novotny, A P Chubb, K Cownley, J A Montaraz.   

Abstract

A method was developed which is suitable for the isolation of substantial quantities of outer membrane proteins of Bordetella species in a water-soluble form. The extracted material may then be further fractionated in the absence of detergents by ion-exchange chromatography and preparative flat-bed isoelectrofocusing. These procedures facilitated the isolation of one of the proteins, of molecular weight 68,000, for which the antibody titer correlated with the degree of protection against nasal changes induced in specific-pathogen-free piglets by Bordetella bronchiseptica infection (P. Novotny, M. Kobisch, K. Cownley, A. P. Chubb, and J. A. Montaraz, Infect. Immun. 50:190-198). This protein, which banded between 7.0 and 7.6 pH in preparative isoelectrofocusing, may be further purified with a monoclonal immunosorbent. Immunopurified protein showed adenylate cyclase activity. The enzymatic activity was found to be unstable during processing; i.e., although the crude extract showed up to 150 nmol of cyclic AMP per mg/min, the immunopurified protein showed a maximum of only 200 nmol of cyclic AMP per mg/min. Two strains of B. bronchiseptica, isolated from herds of healthy pigs showing no signs of atrophic rhinitis, did not produce the 68,000-molecular-weight protein and were negative for adenylate cyclase. However, it is not known whether the 68,000-molecular-weight protein is a component of adenylate cyclase or whether it is an unrelated protein associated with this enzyme in some unknown way. Adenylate cyclase activity from culture supernatants of B. bronchiseptica, B. pertussis, and B. parapertussis can be absorbed equally to the same monoclonal immunosorbent.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4044033      PMCID: PMC262156          DOI: 10.1128/iai.50.1.199-206.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  The use of Bordetella pertussis preserved in liquid nitrogen as a challenge suspension in the Kendrick mouse protection test.

Authors:  P Novotny; J E Brookes
Journal:  J Biol Stand       Date:  1975

2.  The L-form of haemophilus pertussis.

Authors:  R G WITTLER
Journal:  J Gen Microbiol       Date:  1951-11

3.  Conversion of Bordetella pertussis to Bordetella parapertussis.

Authors:  N H Kumazawa; M Yoshikawa
Journal:  J Hyg (Lond)       Date:  1978-08

4.  Evaluation of Bordetella bronchiseptica vaccines in specific-pathogen-free piglets with bacterial cell surface antigens in enzyme-linked immunosorbent assay.

Authors:  P Novotny; M Kobisch; K Cownley; A P Chubb; J A Montaraz
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

5.  Determination of protein: a modification of the Lowry method that gives a linear photometric response.

Authors:  E F Hartree
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

6.  The spheroplasts of bordetella pertussis.

Authors:  M A Mason
Journal:  Can J Microbiol       Date:  1966-06       Impact factor: 2.419

7.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

8.  Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis.

Authors:  A A Weiss; E L Hewlett; G A Myers; S Falkow
Journal:  J Infect Dis       Date:  1984-08       Impact factor: 5.226

9.  Modulation of Bordetella pertussis by nicotinic acid.

Authors:  W L McPheat; A C Wardlaw; P Novotny
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

10.  Soluble adenylate cyclase from the culture medium of Bordetella pertussis: purification and characterization.

Authors:  E Hewlett; J Wolff
Journal:  J Bacteriol       Date:  1976-08       Impact factor: 3.490

View more
  23 in total

1.  Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis.

Authors:  L Bassinet; P Gueirard; B Maitre; B Housset; P Gounon; N Guiso
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Replacement of adenylate cyclase toxin in a lineage of Bordetella bronchiseptica.

Authors:  Anne M Buboltz; Tracy L Nicholson; Mylisa R Parette; Sara E Hester; Julian Parkhill; Eric T Harvill
Journal:  J Bacteriol       Date:  2008-06-13       Impact factor: 3.490

3.  Identification of a 68-kilodalton outer membrane protein as the major protective antigen of Bordetella bronchiseptica by using specific-pathogen-free piglets.

Authors:  M Kobisch; P Novotny
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

4.  Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica.

Authors:  Anne M Buboltz; Tracy L Nicholson; Laura S Weyrich; Eric T Harvill
Journal:  Infect Immun       Date:  2009-07-13       Impact factor: 3.441

5.  Characterization of the fim2 and fim3 fimbrial subunit genes of Bordetella bronchiseptica: roles of Fim2 and Fim3 fimbriae and flagella in adhesion.

Authors:  P H Savelkoul; D P de Kerf; R J Willems; F R Mooi; B A van der Zeijst; W Gaastra
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

6.  Use of the promoter fusion transposon Tn5 lac to identify mutations in Bordetella pertussis vir-regulated genes.

Authors:  A A Weiss; A R Melton; K E Walker; C Andraos-Selim; J J Meidl
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

7.  Novel phase-shift marker in cell surface proteins of Bordetella bronchiseptica.

Authors:  M Kuzuya; Y Kodama
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

8.  Evaluation of Bordetella bronchiseptica vaccines in specific-pathogen-free piglets with bacterial cell surface antigens in enzyme-linked immunosorbent assay.

Authors:  P Novotny; M Kobisch; K Cownley; A P Chubb; J A Montaraz
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

9.  Clonal diversity and host distribution in Bordetella bronchiseptica.

Authors:  J M Musser; D A Bemis; H Ishikawa; R K Selander
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

10.  Stimulation of bone resorption by inflamed nasal mucosa, dermonecrotic toxin-containing conditioned medium from Pasteurella multocida, and purified dermonecrotic toxin from P. multocida.

Authors:  T G Kimman; C W Löwik; L J van de Wee-Pals; C W Thesingh; P Defize; E M Kamp; O L Bijvoet
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.